BLS Pharmaceuticals Ltd

NEW
FRA:PR80 (Australia)  
€ 0.55 -0.0090 (-1.6%) Aug 27
25.36
P/B:
10.31
Market Cap:
€ 128.42M ($ 149.57M)
Enterprise V:
€ 127.04M ($ 147.97M)
Volume:
0
Avg Vol (2M):
1.88K
Trade In:

BLS Pharmaceuticals Ltd (FRA:PR80) Dividend

BLS Pharmaceuticals Ltd (FRA:PR80) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -50.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:PR80 Dividend

Does BLS Pharmaceuticals Ltd (FRA:PR80) pay a dividend?

BLS Pharmaceuticals Ltd (FRA:PR80) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BLS Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BLS Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -50.1% over the past 3 years.

What are dividend-paying alternatives to BLS Pharmaceuticals Ltd?

For dividend-paying alternatives in BLS Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.